Core Viewpoint - The ongoing trademark dispute between Wanglaoji and JDB has intensified, focusing on the overseas trademark ownership of "Wanglaoji" as both companies exchange statements and claims regarding their rights [2][4][9]. Group 1: Trademark Dispute - JDB recently claimed ownership of the overseas "Wanglaoji" trademark, citing victories in multiple legal cases in Canada and the EU [5][9]. - Wanglaoji responded sharply, asserting that the trademark rights belong to Guangzhou Pharmaceutical Group and accusing JDB of misleading the public [7][8]. - The dispute has historical roots dating back to 2011, with various legal battles and arbitration outcomes affecting both parties [12][14]. Group 2: Market Position and Strategy - Wanglaoji reported a revenue of 6.499 billion yuan in the first half of 2025, marking an 8.38% year-on-year increase, with profits also rising significantly [9]. - The company is actively expanding its international presence, having registered "Wanglaoji" and "WALOVI" trademarks in over 100 countries and regions [8][10]. - JDB is also pursuing international growth, having registered the "Wanglaoji" trademark in over 60 countries and emphasizing its marketing efforts to promote Chinese herbal tea globally [10][11]. Group 3: Industry Context - The plant beverage market is experiencing rapid growth, with a compound annual growth rate of nearly 10% from 2019 to 2024, indicating a favorable environment for both companies [11]. - As of June 2025, Wanglaoji holds a 46.33% market share in the plant beverage category, while JDB follows with 28.31% [11].